The Lancet Study Highlights New Cancer Risk Factors in India
A landmark study published in the prestigious medical journal The Lancet has shed light on the heavy toll of infections in driving cancer cases across India. According to the research findings, India was projected to witness roughly 1.56 million new cancer cases alongside over 900,000 deaths. Among these total figures, nearly 1.9 million cancer instances were directly associated with various infectious agents.
Experts clarify that contracting an infection does not automatically translate into developing cancer. Instead, the study specifically focused on pathogens that possess a well-established scientific link to certain malignancies. Preventing and managing these specific infections could play a monumental role in alleviating the heavy cancer burden on the healthcare system.
HPV and the Cervical Cancer Threat
Human Papillomavirus (HPV) emerged as the single largest contributor to infection-related cancers within the country, accounting for over one hundred thousand cases. HPV is predominantly connected to cervical cancer in women. Public health advocates continually emphasize the availability of preventive HPV vaccines and timely medical screenings as crucial tools to intercept the disease at an early, treatable stage.
The Role of H. pylori in Stomach Malignancies
Another major pathogen identified in the global and domestic research is Helicobacter pylori, a bacterium responsible for roughly 47,000 stomach cancer cases in India. Specialists note that while H. pylori infections are common and often contracted during childhood without immediate symptoms, prolonged inflammation caused by the bacteria can eventually lead to severe gastric complications if left untreated.
